OSIMERTINIB vs RIBOCICLIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OSIMERTINIB vs RIBOCICLIB: Safety Overview
| Metric | OSIMERTINIB | RIBOCICLIB |
|---|---|---|
| Total FAERS Reports | 27,750 | 27,997 |
| Deaths Reported | 12,456 | 4,501 |
| Death Rate | 44.9% | 16.1% |
| Hospitalizations | 5,277 | 6,700 |
| Average Patient Age | 68.2 yrs | 60.2 yrs |
| % Female Patients | 66.0% | 99.0% |
| FDA Approval Date | Nov 13, 2015 | Mar 13, 2017 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Novartis Pharmaceuticals Corporation |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |